Novel Life Science Reagents
All
Pharmaceutical Intermediates
Active Pharma Ingredients(API)
Drug Impurities
Novel Life Science Reagents
Natural Bulk Compounds
Botanical & Herbal Extracts
Health & Nutrition
Pharmaceutical Excipients
| Product Name | CAS No. | Specification | Application | Registration |
| Docosahexaenoic Acid (DHA) | 6217-54-5 | |||
| Capsiate | 205687-01-0 | |||
| St. John's Wort Extract, Hypericin 0.3% | 548-04-9(Hypericin) | 0.3% Hypericin; 50%+HPLC (synthetic) | ||
| Lupeol | 545-47-1 | |||
| Fidaxomicin | 873857-62-6 | |||
| Ansamitocin P-3 | 66584-72-3 | |||
| Artemisinin | 63968-64-9 | |||
| Etanercept | 185243-69-0 | |||
| Exenatide Acetate | 141732-76-5 | 98%Min. HPLC | ||
| β-Thio-NAD (Thio-NAD) | 4090-29-3 | 95%Min.HPLC | ||
| Vitamin D4 | 511-28-4 | 98%Min.HPLC | ||
| SN-38 | 86639-52-3 | HPLC>99% | ||
| Nomilin | 1063-77-0 | 98%Min.HPLC | ||
| Aristolochic Acid A | 313-67-7 | 98%Min.HPLC | ||
| Ercalcitriol (1α,25-Dihydroxyvitamin D2) | 60133-18-8 | 98%Min. | ||
| Chlortetracycline Hydrochloride | 64-72-2 | EP 9.0 | ||
| Fluocinolone Acetonide | 67-73-2 | BP2015 | ||
| Genipin | 6902-77-8 | |||
| Lamivudine | 134678-17-4 | USP38 | ||
| Idarubicin Hydrochloride | 57852-57-0 |
| Product Name | CAS No. | Specification | Application | Registration |
| β-Thio-NAD (Thio-NAD) | 4090-29-3 | 95%Min.HPLC | ||
| SN-38 | 86639-52-3 | HPLC>99% | ||
| Chlortetracycline Hydrochloride | 64-72-2 | EP 9.0 | ||
| Abiraterone | 154229-19-3 | |||
| Cidofovir Anhydrous | 113852-37-2 | |||
| Nintedanib | 656247-17-5 | |||
| Sulfobutyl Ether-β-Cyclodextrin Sodium salt (SBE-β-CD) | 182410-00-0 | |||
| (6R)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride | 69056-38-8 | In-House Standard | ||
| tert-Butyl [(1S,2R)-1-benzyl-2-hydroxy-3-(isobutylamino)propyl]carbamate | 160232-08-6 | In-House Standard | ||
| 2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate; T9 | 134790-39-9 | In-House Standard | ||
| Bumetanide | 28395-03-1 | |||
| Leuprorelin Acetate | 74381-53-6 | |||
| Gemcitabine Base | 95058-81-4 | |||
| L-Biopterin | 22150-76-1 | In-House Standard | N/A |
| Product Name | CAS No. | Specification | Application | Registration |
| Fidaxomicin | 873857-62-6 | |||
| Exenatide Acetate | 141732-76-5 | 98%Min. HPLC | ||
| Fluocinolone Acetonide | 67-73-2 | BP2015 | ||
| Lamivudine | 134678-17-4 | USP38 | ||
| Idarubicin Hydrochloride | 57852-57-0 | |||
| Daunorubicin Hydrochloride | 23541-50-6 | Antineoplastic Agents | ||
| Epirubicin Hydrochloride | 56390-09-1 | Antineoplastic Agents | ||
| Ixabepilone | 219989-84-1 | |||
| Everolimus | 159351-69-6 | |||
| Emtricitabine | 143491-57-0 | |||
| Entecavir Monohydrate | 209216-23-9 | |||
| Vismodegib (GDC-0449) | 879085-55-9 | |||
| Regadenoson Monohydrate | 313348-27-5 | |||
| Ulipristal Acetate | 126784-99-4 | |||
| Tofacitinib (CP-690550) | 477600-75-2 | |||
| Tofacitinib (CP-690550) Citrate | 540737-29-9 | |||
| Abiraterone Acetate | 154229-18-2 | |||
| Nelarabine | 121032-29-9 | |||
| Bortezomib | 179324-69-7 | |||
| Combretastatin A4 Phosphate (CA4P) Disodium Salt | 168555-66-6 |
| Product Name | CAS No. | Specification | Application | Registration |
| 7-Epi-Paclitaxel (7-Epitaxol) | 105454-04-4 | In-House Standard | Paclitaxel EP Impurity E | N/A |
| Abiraterone Isopropyl Ether; AB-IMP-13 | N A | In-House Standard | ||
| Abiraterone Ethyl Ether; AB-IMP-12 | N A | In-House Standard |
| Product Name | CAS No. | Specification | Application | Registration |
| Capsiate | 205687-01-0 | |||
| Ansamitocin P-3 | 66584-72-3 | |||
| Etanercept | 185243-69-0 | |||
| Vitamin D4 | 511-28-4 | 98%Min.HPLC | ||
| Ercalcitriol (1α,25-Dihydroxyvitamin D2) | 60133-18-8 | 98%Min. | ||
| Verteporfin | 129497-78-5 | |||
| Brefeldin A | 20350-15-6 | |||
| Cetuximab | 205923-56-4 | Antineoplastic Agent | ||
| Trastuzumab | 180288-69-1 | Antineoplastic Agent | ||
| ICG-001 | 847591-62-2 | 98%Min.HPLC | ||
| Anakinra (IL-1Ra) | 143090-92-0 | Rheumatoid Arthritis | ||
| Mertansine; DM 1 | 139504-50-0 | In-House Standard | ||
| Temoporfin | 122341-38-2 | In-House Standard | ||
| Y-27632 Dihydrochloride | 129830-38-2 | In-House Standard | ||
| Resatorvid (TAK-242) | 243984-11-4 | In-House Standard |
| Product Name | CAS No. | Specification | Application | Registration |
| Lupeol | 545-47-1 | |||
| Artemisinin | 63968-64-9 | |||
| Nomilin | 1063-77-0 | 98%Min.HPLC | ||
| Aristolochic Acid A | 313-67-7 | 98%Min.HPLC | ||
| Genipin | 6902-77-8 | |||
| Forskolin | 66575-29-9 | |||
| Salidroside | 10338-51-9 | |||
| EGCG | 989-51-5 | |||
| Cycloastragenol | 78574-94-4 | |||
| Astragaloside IV | 84687-43-4 | |||
| Cyclopamine | 4449-51-8 | In-House Standard | ||
| (+)-Bicuculline | 485-49-4 | In-House Standard |
| Product Name | CAS No. | Specification | Application | Registration |
| St. John's Wort Extract, Hypericin 0.3% | 548-04-9(Hypericin) | 0.3% Hypericin; 50%+HPLC (synthetic) |
| Product Name | CAS No. | Specification | Application | Registration |
| Docosahexaenoic Acid (DHA) | 6217-54-5 | |||
| Vitamin B6 (Pyridoxine Hydrochloride) | 58-56-0 | |||
| Ectoine | 96702-03-3 | 98%Min.HPLC | ||
| Dipeptide Diaminobutyroyl Benzylamide Diacetate | 823202-99-9 | 98%Min. HPLC |
| Product Name | CAS No. | Specification | Application | Registration |